| ERIS Lifesciences Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 540596 |
NSE Symbol : ERIS |
P/E(TTM) : 93.14 |
|
ISIN Demat : INE406M01024 |
Div & Yield% : - |
EPS(TTM) : 15.14 |
|
Book Value(₹) : 185.48 |
Market Cap(₹Cr) : 19,189.53 |
Face Value(₹) : 1.00 |
| Particulars | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|---|---|
| Gross Sales | 449.17 | 332.25 | 315.96 | 402.26 | 404.29 | 308.36 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 449.17 | 332.25 | 315.96 | 402.26 | 404.29 | 308.36 |
| Other Operating Income | 7.52 | 9.05 | 8.45 | 7.45 | 7.00 | 6.23 |
| Other Income | 5.16 | 20.39 | 3.43 | 6.98 | 4.03 | 4.26 |
| Total Income | 461.85 | 361.69 | 327.85 | 416.68 | 415.32 | 318.84 |
| Total Expenditure | 333.31 | 261.91 | 249.98 | 265.22 | 255.78 | 203.09 |
| PBIDT | 128.54 | 99.78 | 77.87 | 151.47 | 159.54 | 115.75 |
| Interest | 56.17 | 28.89 | 15.14 | 6.55 | 6.84 | 2.96 |
| PBDT | 72.37 | 70.89 | 62.73 | 144.92 | 152.70 | 112.79 |
| Depreciation | 45.55 | 29.14 | 28.08 | 25.00 | 20.16 | 17.28 |
| Tax | 4.69 | 8.24 | 5.83 | 21.84 | 21.74 | 17.01 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 5.09 | -6.00 | -2.84 | -19.73 | 0.04 | -9.34 |
| Reported Profit After Tax | 17.04 | 39.51 | 31.66 | 117.81 | 110.76 | 87.84 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 17.04 | 39.51 | 31.66 | 117.81 | 110.76 | 87.84 |
| EPS (Unit Curr.) | 1.25 | 2.90 | 2.33 | 8.66 | 8.14 | 6.46 |
| EPS (Adj) (Unit Curr.) | 1.25 | 2.90 | 2.33 | 8.66 | 8.14 | 6.46 |
| Calculated EPS (Unit Curr.) | 1.25 | 2.90 | 2.33 | 8.66 | 8.14 | 6.46 |
| Calculated EPS (Adj) (Unit Curr.) | 1.25 | 2.90 | 2.33 | 8.66 | 8.14 | 6.46 |
| Calculated EPS (Ann.) (Unit Curr.) | 5.01 | 11.61 | 9.31 | 34.64 | 32.58 | 25.84 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 5.01 | 11.61 | 9.31 | 34.64 | 32.58 | 25.84 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 13.61 | 13.61 | 13.60 | 13.60 | 13.60 | 13.60 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 28.62 | 30.03 | 24.65 | 37.65 | 39.46 | 37.54 |
| PBDTM(%) | 16.11 | 21.34 | 19.85 | 36.03 | 37.77 | 36.58 |
| PATM(%) | 3.79 | 11.89 | 10.02 | 29.29 | 27.40 | 28.49 |